Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortress Biotech, Inc. - Common Stock (NQ:FBIO)

3.760 -0.070 (-1.83%)
Streaming Delayed Price Updated: 11:26 AM EDT, Sep 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortress Biotech, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Let's uncover which stocks are experiencing notable gaps during today's session.
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Why Fortress Biotech Shares Are Tumbling Today
Fortress Biotech Inc (NASDAQ: FBIO) shares are trading lower by over 18% after it announced the pricing of a  
Via Benzinga
Roth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
These stocks are moving in today's pre-market session
Discover the top movers in Monday's pre-market session and stay informed about market dynamics. 
Via Chartmill
India-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: Details
Sun Pharma to acquire Checkpoint Therapeutics for $4.10 per share, with potential CVR. FDA approves Unloxcyt, the first PD-L1 blocker for advanced cSCC. 
Via Benzinga
Why Fortress Biotech (FBIO) Stock Is Getting Hammered
Fortress Biotech shares are trading lower by 20% Friday afternoon. The company announced the pricing of a $8 million registered direct offering and concurrent private placements. 
Via Benzinga
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Around $10M Bet On This Tech & Telecom Stock? Check Out These 3 Stocks Insiders Are Buying
 
Via Benzinga
Insiders Buying Fortress Biotech And 2 Other Stocks
 
Via Benzinga
Greenbrier, Fortress Biotech And 3 Stocks To Watch Heading Into Monday
 
Via Benzinga
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday?
Mustang Bio shares soar 190.9% on high trading volume as Phase 1/2 trial data for CAR T-cell therapy MB-106 shows positive results. 
Via Benzinga
FBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one. 
Via InvestorPlace
FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023
FBIO stock results show that Fortress Biotech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
Via Get News
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
--News Direct-- 
Via News Direct
Lindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from Subsidiaries
New York, Feb 2, 2024 - (Plato Data via 500NewsWire) -- Fortress Biotech (Fortress Bio), a unique biotech company led by industry veteran Dr. Lindsay Rosenwald, focused on identifying, in-licensing and... 
Via TheNewswire.com
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying 
Via Benzinga
Fear & Greed Index Remains In 'Extreme Greed' Zone; S&P 500 Surges 24% In 2023
The CNN Money Fear and Greed index showed some decline in overall market sentiment, but the index remained in the "Extreme Greed" zone on Friday. U.S. stocks closed slightly lower on Friday, but the... 
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Gold Moves Lower; Microbot Medical Shares Slide
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The... 
Via Benzinga
Topics Stocks
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Nasdaq Down Over 100 Points; Fortress Biotech Shares Plummet
U.S. stocks turned lower midway through trading, with the Nasdaq Composite falling more than 100 points on Friday. The Dow traded down 0.34% to 37,583.72 while the NASDAQ fell 0.73% to 14,984.98. The... 
Via Benzinga
Topics Stocks
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.